ConductScience.org, home

Paper6325001

Phase I trial of N-methylformamide.

McVie JG and 3 others. Cancer Treat Rep, 1984. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Phase I trial of N-methylformamide. Papers, record 6325001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6325001

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Phase I trial of N-methylformamide.
PubMed
Journal
Cancer Treat Rep
PubMed
Year
1984
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
3
iCite
Revised in PubMed
2012-11-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McVie JGJ G
2ten Bokkel Huinink WWW W
3Simonetti GG
4Dubbelman RR

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
FormamidesMajor topic
NeoplasmsMajor topic
Adult
Aged
Alkaline Phosphatase
Anorexia
Drug Administration Schedule
Drug Evaluation
Female
Humans
Hyperbilirubinemia
Liver
Male
Middle Aged
Nausea
Peripheral Nervous System Diseases

Source PubMed

Download CSV of topics

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
12888809Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.Br J Cancer2003https://conductscience.org/library/papers/12888809PubMed
11561680N-Methylformamide in advanced squamous cancer of the uterine cervix: an Eastern Cooperative Oncology Group phase II trial.Invest New Drugs2001https://conductscience.org/library/papers/11561680PubMed
3948299The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3948299PubMed
3654153Phase II trial of N-methylformamide in advanced head and neck cancer.Invest New Drugs1987https://conductscience.org/library/papers/3654153PubMed
3552281N-methyl antitumour agents. A distinct class of anticancer drugs?Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/3552281PubMed
3196150Comparative hepatotoxicity and metabolism of N-methylformamide in rats and mice.Arch Toxicol1988https://conductscience.org/library/papers/3196150PubMed
2599802Assessment of N-methylformamide (NMF) administered orally on a three times weekly schedule: a phase I study.Invest New Drugs1989https://conductscience.org/library/papers/2599802PubMed
2384306Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced squamous cancer of the cervix. A Gynecologic Oncology Group study.Invest New Drugs1990https://conductscience.org/library/papers/2384306PubMed
2384305Phase II study of N-methylformamide (N-MF) (NSC 3051) in patients with advanced epithelial ovarian cancer. A Gynecologic Oncology Group study.Invest New Drugs1990https://conductscience.org/library/papers/2384305PubMed
2322987Triple combination of retinoic acid plus actinomycin D plus dimethylformamide induces differentiation of human acute myeloid leukaemic blasts in primary culture.Cancer Chemother Pharmacol1990https://conductscience.org/library/papers/2322987PubMed
2026491Phase II trial of N-methylformamide in patients with metastatic melanoma.Invest New Drugs1991https://conductscience.org/library/papers/2026491PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6325001

GET https://conductscience.org/api/papers/v1/6325001/authors